Cargando…
Comparison of topical purslane & topical 0.1% triamcinolone acetonide in the management of oral lichen planus - a double blinded clinical trial
AIM AND BACKGROUND: Oral lichen planus (OLP) is a chronic autoimmune mucocutaneous disorder of unknown etiology and treatment is targeted at alleviating symptoms. At present, corticosteroids are the mainstay treatment, and their side effects hamper their long-term use, demanding alternative therapy....
Autores principales: | Murugan, Arul Jothi, Ganesan, Anuradha, Aniyan, Yesoda K., Lakshmi, Krithika Chandrasekar, Asokan, Kannan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507837/ https://www.ncbi.nlm.nih.gov/pubmed/37726676 http://dx.doi.org/10.1186/s12903-023-03385-1 |
Ejemplares similares
-
Periodic acid–Schiff staining in oral exfoliative cytology of diabetic patients: The odyssey for noninvasive screening – A systematic review and meta-analysis
por: Aniyan, K. Yesoda, et al.
Publicado: (2023) -
Intralesional and sublesional injection of triamcinolone acetonide for oral lichen planus.
por: Sleeper, H. R.
Publicado: (1967) -
Assessment of 5% Amlexanox, 0.1% Triamcinolone Acetonide and 0.03% Tacrolimus in the Management of Oral Lichen Planus
por: AlMutairi, Mohammed, et al.
Publicado: (2023) -
Alterations of Serum Lipid Profile Patterns in Oral Lichen Planus Patients: A Case–Control Study
por: Aniyan, K. Yesoda, et al.
Publicado: (2018) -
Photodynamic Therapy, Photobiomodulation and Acetonide Triamcinolone 0.1% in the Treatment of Oral Lichen Planus: A Randomized Clinical Trial
por: Salinas-Gilabert, Carmen, et al.
Publicado: (2022)